Phase II Clinical Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

APPROVED_FOR_MARKETING

Conditions studied: Thoracic Aortic Aneurysm, Penetrating Ulcers

In brief

This study is a continuation of the pivotal trial studying the safety and efficacy of the Relay thoracic stent-graft system to treat thoracic aortic aneurysms. Efficacy is being evaluated by the device-related adverse event rate of endovascular repair (via the Relay thoracic stent-graft) through 1 year. Safety is being evaluated by comparing major adverse events through 1 year in subjects treated with the Relay thoracic stent-graft to those who underwent surgical repair.

Key facts

Study ID
NCT01327742
Run by
Bolton Medical
Last updated by the study team
2012-11-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.